Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,143
Closed -$4.31M 217
2021
Q4
$4.31M Hold
8,143
0.46% 38
2021
Q3
$3.79M Hold
8,143
0.44% 39
2021
Q2
$3.86M Hold
8,143
0.44% 39
2021
Q1
$3.74M Hold
8,143
0.4% 42
2020
Q4
$4.34M Sell
8,143
-41
-0.5% -$20.1K 0.43% 33
2020
Q3
$3.93M Sell
8,184
-1,132
-12% -$555K 0.5% 36
2020
Q2
$4.2M Sell
9,316
-3,464
-27% -$1.55M 0.56% 31
2020
Q1
$5.54M Sell
12,780
-3,883
-23% -$1.73M 0.81% 19
2019
Q4
$7.32M Buy
16,663
+3,682
+28% +$1.55M 0.61% 26
2019
Q3
$5.42M Sell
12,981
-3,250
-20% -$1.33M 0.51% 42
2019
Q2
$5.86M Sell
16,231
-2,541
-14% -$849K 0.41% 47
2019
Q1
$6.01M Hold
18,772
0.46% 44
2018
Q4
$5.32M Hold
18,772
0.43% 47
2018
Q3
$6M Sell
18,772
-21
-0.1% -$6.69K 0.13% 193
2018
Q2
$6.05M Hold
18,793
0.11% 214
2018
Q1
$5.13M Hold
18,793
0.1% 229
2017
Q4
$4.57M Sell
18,793
-11,845
-39% -$2.69M 0.09% 255
2017
Q3
$6.19M Sell
30,638
-6,313
-17% -$1.24M 0.12% 224
2017
Q2
$7.56M Buy
36,951
+328
+0.9% +$65.3K 0.15% 194
2017
Q1
$6.69M Hold
36,623
0.13% 216
2016
Q4
$5.88M Sell
36,623
-21,898
-37% -$3.22M 0.12% 227
2016
Q3
$8.26M Buy
58,521
+30,021
+105% +$4.18M 0.17% 185
2016
Q2
$3.88M Sell
28,500
-22,800
-44% -$3.02M 0.09% 221
2016
Q1
$6.95M Buy
51,300
+5,200
+11% +$703K 0.15% 184
2015
Q4
$6.91M Buy
46,100
+2,200
+5% +$325K 0.15% 180
2015
Q3
$5.86M Buy
43,900
+5,700
+15% +$798K 0.13% 191
2015
Q2
$5.01M Buy
38,200
+7,400
+24% +$916K 0.11% 198
2015
Q1
$3.68M Buy
30,800
+4,700
+18% +$522K 0.08% 210
2014
Q4
$2.76M Hold
26,100
0.06% 249
2014
Q3
$2.69M Hold
26,100
0.06% 256
2014
Q2
$2.45M Hold
26,100
0.05% 288
2014
Q1
$2.33M Sell
26,100
-1,000
-4% -$81.5K 0.05% 287
2013
Q4
$2.08M Hold
27,100
0.05% 316
2013
Q3
$1.94M Sell
27,100
-90
-0.3% -$6.4K 0.05% 298
2013
Q2
$1.97M Buy
+27,190
New +$1.99M 0.05% 288

Other funds holding CHE

First Quadrant's CHE Position: Q1 2022 in Review

First Quadrant sold out of Chemed (CHE) in Q1 2022, closing a stake of 8,143 shares — an estimated $4.31M sold.

First Quadrant first reported a position in CHE in Q2 2013 and held it in 35 quarters. The position peaked at $8.26M in Q3 2016. 426 funds tracked by Wall St. Rank hold CHE as of Q1 2022.

  • First Quadrant reported no remaining Chemed position as of Q1 2022 after selling out during the quarter.
  • First Quadrant sold 8,143 Chemed shares in Q1 2022, an estimated $4.31M.
  • First Quadrant first reported a position in Chemed in Q2 2013 and held it in 35 quarters.
  • First Quadrant's Chemed position peaked at $8.26M in Q3 2016.
  • 426 funds tracked by Wall St. Rank held Chemed as of Q1 2022.

Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.